{"id":"https://openalex.org/W3212534729","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.699","title":"699 ATYR2810 an anti-NRP2 monoclonal antibody targets tumor-associated macrophages","display_name":"699 ATYR2810 an anti-NRP2 monoclonal antibody targets tumor-associated macrophages","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3212534729","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.699","mag":"3212534729"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.699","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.699","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.699","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A727.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A727.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068770209","display_name":"Samantha K. Tyler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha Tyler","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031837675","display_name":"Michaela Ferrer","orcid":"https://orcid.org/0009-0007-5641-8210","observed_orcids":["https://orcid.org/0009-0007-5641-8210"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michaela Ferrer","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003221654","display_name":"Erik Escobedo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik Escobedo","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077320383","display_name":"Kaitlyn Rauch","orcid":"https://orcid.org/0000-0002-3845-5997","observed_orcids":["https://orcid.org/0000-0002-3845-5997"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlyn Rauch","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012481584","display_name":"Sofia Klopp-Savino","orcid":"https://orcid.org/0000-0003-0509-8935","observed_orcids":["https://orcid.org/0000-0003-0509-8935"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sofia Klopp-Savino","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034862315","display_name":"Justin Rahman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Rahman","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062006944","display_name":"Zhiwen Xu","orcid":"https://orcid.org/0000-0001-6473-8328","observed_orcids":["https://orcid.org/0000-0001-6473-8328"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhiwen Xu","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006455691","display_name":"Esther Chong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Esther Chong","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033398235","display_name":"Suzanne Paz","orcid":"https://orcid.org/0000-0003-4110-5696","observed_orcids":["https://orcid.org/0000-0003-4110-5696"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne Paz","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056710753","display_name":"Leslie A. Nangle","orcid":"https://orcid.org/0009-0000-6953-7998","observed_orcids":["https://orcid.org/0009-0000-6953-7998"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Nangle","raw_affiliation_strings":["aTyr Pharma, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA, United States","institution_ids":["https://openalex.org/I4210151019"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210151019"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A727","last_page":"A727"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuropilin-2","display_name":"neuropilin-2","score":0.9430000185966492},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8479999899864197},{"id":"https://openalex.org/keywords/zeb1","display_name":"ZEB1","score":0.8259999752044678},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9649999737739563},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.7459999918937683},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7319999933242798},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.5929999947547913},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.6840000152587891},{"id":"https://openalex.org/keywords/chemokine-secretion","display_name":"chemokine secretion","score":0.4950000047683716},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.4320000112056732},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6778879165649414},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.6334846615791321},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5483081340789795},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.46940767765045166},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4509451389312744},{"id":"https://openalex.org/C2775858924","wikidata":"https://www.wikidata.org/wiki/Q18034009","display_name":"CD163","level":4,"score":0.45011743903160095},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4455842077732086},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3861757516860962},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.377094566822052},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3391987085342407},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2981334328651428},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2701108157634735},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.18910279870033264},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11309713125228882},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.699","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.699","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.699","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A727.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.699","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.699","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.699","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A727.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3212534729.pdf","grobid_xml":"https://content.openalex.org/works/W3212534729.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W2042855108","https://openalex.org/W2767071425","https://openalex.org/W2885789377"],"related_works":["https://openalex.org/W4409634715","https://openalex.org/W3179053513","https://openalex.org/W2885789377","https://openalex.org/W3211438072","https://openalex.org/W2492053146","https://openalex.org/W4282980532","https://openalex.org/W4224928666","https://openalex.org/W4313366394","https://openalex.org/W3139231020","https://openalex.org/W3213801820"],"abstract_inverted_index":{"Background":[0],"Neuropilin-2":[1,448,518],"(NRP2)":[2],"is":[3,16,48,200,519],"a":[4,80,221,261,341,368],"single":[5],"transmembrane":[6],"pleiotropic":[7],"receptor":[8],"that":[9,299,326,351],"utilizes":[10],"co-receptors":[11],"for":[12,101,124,295,347,587,593,627],"signal":[13],"transduction":[14],"and":[15,22,35,38,74,96,114,119,161,172,185,193,211,240,267,310,322,393,529,541,549,581],"known":[17,49,301],"to":[18,84,97,135,163,249,252,275,302,356,367,380,532,539,575],"impact":[19],"tumor":[20,305,451,527],"progression":[21,540],"metastasis.1":[23],"Deletion":[24],"of":[25,53,63,78,117,139,155,219,284,336,338,371,388,535,543,584],"NRP2":[26,54,64,199,304,352,372,576],"in":[27,42,55,111,150,179,216,224,255,264,270,288,360,373,390,525],"murine":[28],"tumor-associated":[29],"macrophages":[30,622],"(TAMs)":[31,623],"downregulated":[32],"several":[33],"immunosuppressive":[34],"tumor-promoting":[36,490],"genes":[37,41,580],"upregulated":[39],"immune-stimulatory":[40],"the":[43,51,76,92,137,151,217,281,296,317,334,348,354,526,533,550],"myeloid":[44],"compartment.2":[45],"However,":[46],"little":[47],"about":[50],"role":[52,110,370],"human":[56,314],"TAMs.":[57,142,277,315,374],"We":[58,292,345],"previously":[59],"reported":[60],"significant":[61,222,262],"expression":[62,160,269,359],"on":[65,122,141,203,313,521,625],"TAMs":[66,106,145,247,253,273,285,321,392],"derived":[67],"from":[68,148],"triple":[69],"negative":[70],"breast":[71,103,589],"cancer":[72,126],"(TNBC),3":[73],"demonstrated":[75],"ability":[77,162,283,355],"ATYR2810,":[79,220,300],"monoclonal":[81],"anti-NRP2":[82],"antibody,":[83],"regulate":[85,357],"epithelial-mesenchymal":[86],"transition":[87,113,579],"(EMT)":[88],"genes,":[89],"such":[90,129],"as":[91,130,340],"transcription":[93],"factor":[94],"ZEB1,":[95],"enhance":[98],"chemotherapeutic":[99],"efficacy":[100,583],"aggressive":[102,588],"cancer.4":[104],"Knowing":[105],"play":[107],"an":[108,382],"important":[109],"EMT":[112],"therapy":[115],"resistance":[116],"cancer,":[118],"also":[120,279,308],"rely":[121],"ZEB1":[123,265,358,389,626],"their":[125,225,363,628],"promoting":[127],"roles":[128],"immune":[131,343,522,536],"regulation,5":[132],"we":[133,259,324],"sought":[134],"investigate":[136],"effects":[138,312],"ATYR2810":[140,250,271,278,339],"Methods":[143],"MDA-MB-231":[144],"were":[146,166,188,236],"generated":[147],"monocytes":[149],"presence":[152,218],"or":[153],"absence":[154],"ATYR2810.":[156],"TAM":[157,175],"phenotypes,":[158],"gene":[159,266],"secrete":[164],"cytokines":[165],"assessed":[167],"by":[168,190,196],"flow":[169,191],"cytometry,":[170],"qRT-PCR":[171],"MSD":[173],"respectively.":[174],"suppressive-ness":[176],"was":[177,231],"measured":[178],"co-culture":[180,289],"experiments.":[181,290],"T":[182,207,229,234],"cell":[183,208,452],"proliferation":[184],"activation":[186,210],"markers":[187],"monitored":[189],"cytometry":[192],"cytokine":[194,212,242],"production":[195,243],"MSD.":[197],"Results":[198],"highly":[201],"expressed":[202,520],"TAMs,":[204],"which":[205],"suppress":[206],"proliferation,":[209],"release.":[213],"When":[214],"differentiated":[215,254],"decrease":[223,263],"suppressive":[226,282,364],"capabilities":[227],"against":[228],"cells":[230,235,523],"observed.":[232],"Briefly,":[233],"more":[237],"proliferative,":[238],"active":[239],"altered":[241],"when":[244,286],"co-cultured":[245],"with":[246],"exposed":[248],"compared":[251,274],"its":[256],"absence.":[257],"Interestingly,":[258],"observed":[260],"protein":[268],"treated":[272],"non-treated":[276],"decreased":[280],"present":[287,524],"Conclusions":[291],"show":[293,346],"here":[294],"first":[297,349],"time":[298,350],"bind":[303,309],"cells,":[306],"can":[307],"exert":[311],"Given":[316],"intricate":[318],"relationship":[319],"between":[320],"tumors,":[323],"believe":[325],"this":[327],"novel":[328,369,489],"finding":[329],"provides":[330],"additional":[331],"insight":[332],"into":[333],"mechanism":[335],"action":[337],"potential":[342,379],"regulator.":[344],"has":[353],"TAMs;":[361],"reducing":[362],"nature,":[365],"pointing":[366],"These":[375],"findings":[376],"indicate":[377],"ATYR2810s":[378],"be":[381],"effective":[383],"anti-cancer":[384],"agent":[385],"through":[386],"regulation":[387,537],"both":[391],"tumors.":[394],"References":[395],"Caunt":[396],"M,":[397,444,500,511,565,599],"Mak":[398],"J,":[399,409,415,426,469,561],"Liang":[400],"W-C,":[401],"Stawicki":[402],"S,":[403,457,461,467,473,498,515],"Pan":[404],"Q,":[405],"Tong":[406],"RK,":[407,477],"Kowalski":[408],"Ho":[410],"C,":[411,421,471,502,513,557,563],"Reslan":[412],"HB,":[413],"Ross":[414],"Berry":[416],"L,":[417,507,567,601],"Kasman":[418],"I,":[419],"Zlot":[420],"Cheng":[422],"Z,":[423,555],"Le":[424],"Couter":[425],"Filvaroff":[427],"EH,":[428],"Plowman":[429],"G,":[430],"Peale":[431],"F,":[432],"French":[433],"D,":[434],"Carano":[435],"R,":[436,465,505],"Koch":[437],"AW,":[438],"Wu":[439],"Y,":[440],"Watts":[441],"RJ,":[442],"Tessier-Lavigne":[443],"Bagri":[445],"A.":[446,620],"Blocking":[447],"function":[449],"inhibits":[450],"metastasis.":[453],"2008;13(4):331\u2013342.":[454],"https://doi.org/10.1016/j.ccr.2008.01.029.":[455],"Roy":[456],"Bag":[458],"AK,":[459],"Dutta":[460],"Polavaram":[462],"NS,":[463],"Islam":[464],"Schellenburg":[466],"Banwait":[468],"Guda":[470],"Ran":[472],"Hollingsworth":[474],"MA,":[475],"Singh":[476],"Talmage":[478],"JE,":[479],"Muders":[480],"MH,":[481],"Batra":[482],"SK,":[483],"Datta":[484],"K.":[485],"Macrophage-derived":[486],"neuropilin-2":[487],"exhibits":[488],"functions.":[491],"Cancer":[492,594],"Res":[493],"2018;78(19):5600\u20135617.":[494],"doi:":[495,633],"10.1158/0008\u20135472.CAN-18-0562.":[496],"Tyler":[497],"Ferrer":[499],"Polizzi":[501,562],"Da":[503],"Silva":[504],"Eide":[506],"Walwick":[508],"K,":[509],"Seikkula":[510,564],"Burkart":[512,556],"Paz":[514],"Nangle":[516,570],"L.":[517],"microenvironment,":[528],"may":[530],"contribute":[531],"suppression":[534],"leading":[538],"metastasis":[542],"cancer.":[544,590],"Keystone":[545],"Symposia:":[546],"Tumor":[547],"Metabolism":[548],"Microenvironment.":[551],"2021.":[552,596],"https://www.atyrpharma.com/wp-content/uploads/2021/01/Jan-2021-Keystone-Poster_ST_FINAL.pdf.":[553],"Xu":[554],"Goel":[558],"HL,":[559],"Rahman":[560],"Burman":[566],"Mercurio":[568],"AM,":[569],"LA.":[571],"A":[572],"domain-specific":[573],"antibody":[574],"down-regulated":[577],"epithelial-mesenchymanl":[578],"enhanced":[582],"stnadar-of-care":[585],"therapeutics":[586],"American":[591],"Society":[592],"Research,":[595],"https://www.atyrpharma.com/wp-content/uploads/2021/04/2021Mar_AACR-poster_ZX_Final_v2.pdf.":[597],"Cort\u00e9s":[598],"Sanchez-Moral":[600],"de":[602],"Barrios":[603],"O,":[604],"Fern\u00e1ndez-Ace\u00f1ero":[605],"MJ,":[606],"Mart\u00ednez-Campanario":[607],"MC,":[608],"Esteve-Codina":[609],"A,":[610],"Darling":[611],"DS,":[612],"Gy\u00f3rffy":[613],"B,":[614],"Lawrence":[615],"T,":[616],"Dean,":[617],"DC,":[618],"Postigo":[619],"Tumor-associated":[621],"depend":[624],"cancer-promoting":[629],"roles.":[630],"EMBO":[631],"2017;36(22):3336\u20133355.":[632],"10.15252/embj.201797345.":[634],"Epub":[635],"2017":[636],"Oct":[637],"16.":[638]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2021-11-22T00:00:00"}